Accuray Incorporated (ARAY) Social Stream



Accuray Incorporated (ARAY): $4.47

-0.06 (-1.32%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Featured Post From StockTwits About ARAY

$ARAY Underwhelming results overall but gives longs another 3 months to add.

When a company’s order backlog > market cap you buy. And that’s really only a fraction of what I’m looking at here. GLA
FOXWELL, published April 29, 2021

Other Notable StockTweets About ARAY


PM mOOvers👀

$TSCO -Tractor Supply shares are trading higher after the company reported better-than-expected Q1 EPS and sales. The company also raised its FY21 EPS and sales guidance above analyst estimates.

$HZAC - Vivid Seats, A Leading Concert, Sports And Theater Ticket Marketplace, To Become A Publicly-Listed Company Via Merger With Horizon Acquisition Corporation

$IQV -IQVIA shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company raised its FY21 EPS and sales guidance above analyst estimates.

$XL -XL Fleet Partners with Dickinson Fleet Services to Expand Nationwide Service Support for Growing Electrified Vehicle Deployments

$ARAY -Accuray Receives Shonin Approval for ClearRT™ Helical kVCT Imaging, CE Mark Expected by End of June; Expands Commercial Launch

MakingDreamsReality, published April 22, 2021

$ARAY imho Aray is definitely undervalued cud be few reasons as Varian along with Siemens is too big and could be big competition or street is on the sidelines and will buy once they see asia sales ...they don't want to take risk until they see china sales😀

Kris1334, published April 17, 2021

$ARAY underestimated stock with great tech and massive backlog of orders...imo should be trading over $15 but seems street is not buying the china story yet ..if Aray get a good solid sales going in asia $50 might look cheap jmho do ur dd

Kris1334, published April 13, 2021

$ARAY ASXC This is the future of surgery with Senhance. No other competitor has this kind of AI technology. Senhance will be the gold standard for surgery in the upcoming years. Minimum buyout value 2-4b+ ($30-$50 per share). https://youtu.be/dbCffQHncD0

cali37, published March 23, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5262 seconds.